 |
111 Diseases |  |
73 Trials |
|
73 Trials |  |
1509 News |  |
| «12...25262728293031323334353637 |
- modafinil / Generic mfg., memantine / Generic mfg.
New P1 trial: Effects of Donepezil and Memantine on Cognitive Functions After a Sleep Deprivation Challenge in Healthy Volunteers (clinicaltrials.gov) - Oct 25, 2011
P1, N=36, Recruiting, Sponsor: Qualissima
- memantine / Generic mfg.
New P2b trial: MITIGATE-HD: A Trial of Memantine as Symptomatic Treatment for Early Huntington Disease (clinicaltrials.gov) - Oct 20, 2011
P2b, N=19, Completed, Sponsor: University of British Columbia
- | memantine / Generic mfg.
Enrollment open: AD-IDEA: Alzheimer's Disease - Input of Vitamin D With mEmantine Assay (clinicaltrials.gov) - Oct 10, 2011
P3, N=120, Recruiting, Sponsor: University Hospital, Angers
Not yet recruiting --> Recruiting
- |||| memantine / Generic mfg.
Trial completion: Investigation of Memantine in the Treatment of Memory, Concentration or Attention Problems (clinicaltrials.gov) - Sep 25, 2011
P2, N=299, Completed, Sponsor: Merz Pharmaceuticals GmbH
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- temozolomide / Generic mfg., memantine / Generic mfg., mefloquine / Generic mfg.
Enrollment open: Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy (clinicaltrials.gov) - Sep 14, 2011
P1, N=144, Recruiting, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- | memantine / Generic mfg.
Trial completion: NAMHS: Memantine as a Supplement to Naltrexone in Treating Heroin Dependence (clinicaltrials.gov) - Sep 13, 2011
P2/3, N=82, Completed, Sponsor: New York State Psychiatric Institute
Not yet recruiting --> Recruiting Recruiting --> Completed
- memantine / Generic mfg.
Trial termination: MemAP: Memantine and Antipsychotics Use (clinicaltrials.gov) - Sep 11, 2011
P4, N=19, Terminated, Sponsor: Merz Pharmaceuticals GmbH
Recruiting --> Completed Completed --> Terminated; Study terminated due to too slow enrollment
- memantine / Generic mfg.
Enrollment change: MemAP: Memantine and Antipsychotics Use (clinicaltrials.gov) - Sep 11, 2011
P4, N=19, Terminated, Sponsor: Merz Pharmaceuticals GmbH
Completed --> Terminated; Study terminated due to too slow enrollment N=27 --> 19
- temozolomide / Generic mfg., memantine / Generic mfg., mefloquine / Generic mfg.
New P1 trial: Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy (clinicaltrials.gov) - Sep 6, 2011
P1, N=144, Recruiting, Sponsor: M.D. Anderson Cancer Center